Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pediatr ; 175: 231-2, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27283461

RESUMO

Late-preterm twins with propionic acidemia developed severe hyperammonemic encephalopathy at 5 days of age. Continuous venovenous hemodialysis was performed successfully for both infants via extracorporeal membrane oxygenation pump, and both rapidly improved. They were taken off continuous venovenous hemodialysis and extracorporeal membrane oxygenation and discharged with dietary therapy. At 3 years of age, neurodevelopment showed globally delayed milestones.


Assuntos
Doenças em Gêmeos/terapia , Oxigenação por Membrana Extracorpórea , Hiperamonemia/terapia , Doenças do Prematuro/terapia , Acidemia Propiônica/complicações , Diálise Renal/métodos , Gêmeos Monozigóticos , Doenças em Gêmeos/etiologia , Humanos , Hiperamonemia/etiologia , Recém-Nascido , Recém-Nascido Prematuro , Doenças do Prematuro/etiologia , Masculino
2.
JPEN J Parenter Enteral Nutr ; 40(1): 67-72, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25921560

RESUMO

BACKGROUND: Nutrition support with parenteral nutrition (PN) is associated with gut atrophy. Prior studies have shown improvement with enteral chenodeoxycholic acid, a dual agonist for the farnesoid X receptor (FXR) and bile acid receptor TGR5. We hypothesized that gut growth is induced by TGR5 activation, and gut atrophy during PN administration could be prevented with the TGR5-specific agonist oleanolic acid (OA). METHODS: Neonatal pigs were implanted with duodenal and jugular vein catheters. Animals were provided equi-nutritious PN or enteral swine milk. A PN subgroup received enteral OA at 50 mg/kg/d. RESULTS: PN caused marked gut atrophy compared with enterally fed (EN) control animals. OA treatment led to preservation of gut mass demonstrated grossly and histologically. The mean ± SD gut weight as a percentage of body weight was 4.30 ± 0.26 for EN, 1.92 ± 0.06 for PN (P < .05, EN vs PN), and 3.39 ± 0.79 for PN+OA (P < .05, PN+OA vs PN). Mean ± SD gut density (g/cm) was 0.31 ± 0.03 for EN, 0.18 ± 0.03 for PN (P < .05 EN vs PN), and 0.27 ± 0.01 for PN+OA (P < .05 PN+OA vs PN). Histologically, a markedly decreased villous to crypt ratio was noted with PN, and OA significantly prevented this decrease. The mean ± SD v/c ratio was 3.51 ± 0.59 for EN, 1.69 ± 0.10 for PN (P < .05, EN vs PN), and 2.90 ± 0.23 for PN+OA (P < .05, PN+OA vs PN). Gut TGR5 messenger RNA expression was significantly elevated with OA treatment compared with both PN and EN. CONCLUSION: The bile acid-activated G protein-coupled receptor TGR5 agonist OA prevented gut atrophy associated with PN.


Assuntos
Trato Gastrointestinal/efeitos dos fármacos , Trato Gastrointestinal/patologia , Ácido Oleanólico/farmacologia , Nutrição Parenteral/efeitos adversos , Animais , Animais Recém-Nascidos , Atrofia , Modelos Animais de Doenças , Feminino , Tamanho do Órgão/efeitos dos fármacos , Receptores Acoplados a Proteínas G/agonistas , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo , Suínos
3.
Nutr Res ; 35(2): 169-74, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25649660

RESUMO

Total parenteral nutrition (TPN) provides all nutrition intravenously. Although TPN therapy has grown enormously, it causes significant complications, including gut and hepatic dysfunction. Current models use animal tethering which is unlike ambulatory human TPN delivery and is cost prohibitive. We hypothesize that using ultramobile infusion pumps, TPN can be delivered cost-effectively, resulting in classical gut and hepatic injury, and we thus aim to establish a new model system. Neonatal pigs (n=8) were implanted with jugular vein and duodenal catheters. Animals were fitted in dual-pocket jackets. An ultramobile ambulatory pump was placed in one pocket and connected to the jugular vein or duodenal catheter. Isocaloric TPN or swine formula was placed in the other pocket. Rigorous Wifi-based video and scheduled monitoring was performed. After 14days, the animals were euthanized. The mean (±SD) daily weight gain (in grams) for enteral-fed control (EN) vs TPN animals was 102.4±10.8 and 91.03±12.1 respectively (P<.05). Total parenteral nutrition resulted in significant conjugated bilirubin elevation and hepatomegaly. Mean (±SD) serum conjugated bilirubin (in µmol/L) was 1.5±0.7 for EN and 6.3±2.8 for TPN (P<.05). Marked gut atrophy was noted with TPN. The mean (±SD) gut weight as a percent of body weight was 4.30±0.26 for EN and 2.62±0.48 for TPN (P<.05). Surgical sites healed well. All animals remained completely mobile. We thus established that TPN can be successfully delivered using ultramobile pumps and believe that this remains the first such description of an ambulatory piglet TPN model system. In addition to cholestasis and gut atrophy, classical TPN-induced injury was documented.


Assuntos
Vias de Administração de Medicamentos , Nutrição Enteral/métodos , Hiperbilirrubinemia/etiologia , Mucosa Intestinal/patologia , Fígado/efeitos dos fármacos , Nutrição Parenteral Total/efeitos adversos , Animais , Animais Recém-Nascidos , Atrofia , Peso Corporal/efeitos dos fármacos , Nutrição Enteral/efeitos adversos , Hiperbilirrubinemia/sangue , Infusões Intravenosas/métodos , Mucosa Intestinal/efeitos dos fármacos , Fígado/metabolismo , Nutrição Parenteral Total/métodos , Suínos , Resultado do Tratamento , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...